UPDATED: Shire finally gets it done, bagging Baxalta in $32B buyout

John Carroll

It took a few months, but has wrapped a $ 32 billion deal to acquire , providing CEO Flemming Ornskov with the big merger that he has been promising investors.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS